Bioprinting with live cells by Özler, Saime Burçe et al.
  
 
 
Bioprinting with Live Cells 
S. Burce Ozler, Can Kucukgul and Bahattin Koc 
 1 1   Introduction 
2 
3 
The loss or failure of an organ or tissue is one of the most devastating, and costly  
4 problems in health care. The current treatment methods for organ/tissue loss or  
5 failure include transplantation of organs, surgical reconstruction, use of mechani- 
6 cal devices, or supplementation of metabolic products. Due to the growing need  
7 for organ transplantation and a lack of donor organs, tissue or organ engineering  
8 has progressed as a multidisciplinary field combining life sciences and engineering  
9 principles to restore, maintain, or improve function of tissues or organs [1, 2]. 
10 
Traditionally, tissue engineering strategies are based on the cell seeding into syn- 
11 thetic, biological or composite scaffolds providing a suitable environment for cell  
12 attachment, proliferation and differentiation. A scaffold is highly porous complex  
13 structure providing an interconnected network that is designed to act as an artificial  
14 extracellular matrix (ECM) until the cells form their own ECM. In scaffold-based  
15 tissue engineering, three steps must be followed including finding a source of pre- 
16 cursor cells from the patient, seeding these cells in vitro into the desired places of  
17 scaffold and surgically implanting the scaffold into the patient [3]. Scaffolds have  
18 been used to fabricate various tissue grafts including skin, cartilage, bone, blood  
19 vessels, bladder and myocardium [4–12]. Bioengineered tissue scaffolds attempt  
20 to mimic both the external shape and internal architecture of the replaced tissues.  
21 
The modeling of scaffolds has a great impact on the growth and proliferation of  
22 cells and a spatially and temporally controlled scaffold design could improve cell  
23 growth and differentiation [13]. Although many different scaffold manufacturing  
24 techniques such as salt-leaching, porogen melting, gas foaming, electrospinning,  
 2 S. B. Ozler et al. 
B. Koc () · S. B. Ozler · C. Kucukgul  
Department of Manufacturing and Industrial Engineering, 
Sabanci University, Istanbul, Turkey e-mail: 
bahattinkoc@sabanciuniv.edu 
 © Springer International Publishing Switzerland 2016 1 
K. Turksen (eds.), Bioprinting in Regenerative Medicine,   
Stem Cell Biology and Regenerative Medicine, DOI 10.1007/978-3-319-21386-6_3 
25 fiber deposition, molding and freeze-drying have been investigated in the past, it is 26 
challenging to control pore size, porosity, pore interconnectivity and external geom27 etries 
of scaffolds. In recent years, various additive manufacturing based methods 28 such as 
bioplotting, bioprinting, ink-jet printing and stereolithography have been  
29 used for biomanufacturing of complex three-dimensional (3D) tissue scaffolds to  
30 overcome the limitations of conventional tissue engineering methods [14]. These 31 
additive manufacturing based techniques allow to fabricate scaffolds layer-by-layer 
32 with controlled external and internal geometries based on computer-aided models  
33 of targeted tissues [15]. Several researchers have investigated designing function34 ally 
gradient porous scaffolds with controllable variational pore size and heteroge35 neous porous 
architecture [16, 17]. 
36 In scaffold-based tissue engineering, different biomaterials are used for scaffold 37 
fabrication such as porous materials composed of biodegradable polymers (polylac38 tic acid, 
polyglycolic acid, hyaluronic acid and several copolymers), hydroxyapatite 39 or calcium 
phosphate-based materials and soft materials like collagens, fibrin, and 40 various hydrogels. 
Although there is a plenty of choice for scaffold materials, an 41 ideal biomaterial for scaffold 
fabrication should be nontoxic, nonimmunogenic, ca42 pable of maintaining mechanical 
integrity for tissue growth and differentiation with 43 controlled degradation [3]. 
44 After implantation of a scaffold, it should degrade in a controlled manner and 45 the seeded 
cells should proliferate and migrate into scaffold to replace the scaffold 46 biomaterial. 
Newly-formed extracellular matrix (ECM) fills the places which were  
47 previously occupied by the biomaterial of scaffolds. However, there are some draw48 backs 
to create tissues with biodegradable scaffolds. Mostly, oxygen/nutrient deliv49 ery and 
removal of metabolic waste are insufficient through the micro-channels of 50 a scaffold. 
Additionally, biodegradation of the scaffold induces inflammation. Even 51 though the 
biomaterials used may not be directly toxic, they can be metabolized to 52 toxic byproducts 
[18]. 
53 Because of the above mentioned drawbacks, the recent tissue engineering studies 54 tend 
towards ‘scaffold-free’ techniques. During the embryonic maturation, tissues 55 and organs 
are formed without the need for any scaffolds [19, 20]. The self-assem56 bly and self-
organizing capabilities of cells and tissues are main driver for the field 57 of scaffold-free 
tissue engineering. Self-assembly based tissue engineering aims to 58 produce fully biological 
tissues with specific compositions and shapes having the 59 ability to grow their own ECM, 
and therefore to reduce the immunogenic reactions 60 and other unpredicted complications 
based on the use of scaffolds [21]. 
61 One way of implementing the self-assembly approach is the cell sheet technol62 ogy, which 
has been applied clinically for the repair of skin, cornea, blood vessels, 63 and cardiomyocyte 
patches to repair partial heart infarcts [18, 22, 23]. Another self64 assembly-based approach 
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is founded on the recognition that ‘nature knows best’. 65 This approach relies on the principle 
that cell aggregates can be used as building 66 blocks, since they have the intrinsic capacity 
to fuse together, known as tissue flu67 idity and self-assemble through morphogenetic 
processes if they are deposited in  
68 close spatial organization [24–26]. The engineering of 3D living structures sup- 
ported by the self-assembly and self-organizing capabilities of cells is commonly  
69 termed ‘bioprinting’. Bioprinting is an extension of tissue engineering, where the 
70 cells are delivered through the application of additive manufacturing techniques  
71 [27, 28] 
72 This chapter focuses on scaffold-free tissue engineering and its adaptation to 73 the 
technology of three dimensional bioprinting. Further, the importance as well as 74 
the challenges for 3D bioprinting using stem cells will be discussed in this chapter. 
75 
76 
77 
 78 2  Bioprinting with Live Cells  
79 
 80 2.1   2D Patterning and Cell-Sheet Technology 
81 
82 
Placing cells into special patterns using the laser light has been one of the first 83 
methods used for 2D cell patterning [14]. These laser-based techniques utilize trans84 parent 
ribbons on which one side is coated with cells that are either adhered to a 85 biological 
polymer through initial cellular attachment or uniformly suspended in a 86 thin layer of liquid 
or a hydrogel. A pulsed laser beam is transmitted through the 87 ribbon and is used to push 
cells from the ribbon to the receiving substrate which is  
88 coated with hydrogels. 
89 
While laser based approaches enable to pattern living cells on a substrate [30] 90 
and to layer multiple cell types [31], laser-based techniques have been also explored 91 for 
positioning of cells in microarrays [32]. The resolution of laser-assisted bio92 printing is 
affected by different factors such as the laser fluence, the wettability of 93 the substrate, and 
the thickness and the viscosity of the biological layer [33]. Guil94 lotion and his group studied 
the effect of the viscosity of the bioink, laser energy,  
95 and laser printing speed on the resolution of cell printing [34] as shown in Fig. 1. 96 
By using this method, various cell types including human osteosarcama, rat car97 
diac cells and human umbilical vein endothelial cells (HUVEC) could be printed 98 with 
micrometer accuracy on Matrigel as the absorptive layer [31, 35, 36]. More 99 recently, the 
biological laser printing was used to print sodium alginate, nano-sized 100 hydroxyapatite 
(HA) and human endothelial cells [37]. However, most of these 101 methods are limited to 
two-dimensional patterning and it is difficult to fabricate 102 three-dimensional tissue 
constructs because of process-induced cell injury. The 103 thermal stress and ultraviolet 
radiation caused by laser printing could also affect  
104 the cell viability. 
105 
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Similar to 2D patterning, cell sheet technology is another scaffold-free method 
106 for construction of 2D and 3D engineered tissues. In this method, cells can be re107 moved 
from a culture dish as a relatively stable confluent monolayer sheet without 108 destroying 
cell-cell contacts. In order to build a substantial 3D tissue volume, many 109 sheets need to 
be culminated in high amount of cells which requires vascularization  
110 for cell viability [15]. 
111 
L’Heureux and his group produced a tissue engineered blood vessel using a 
cell112 sheet approach based on cultured human cells. The developed vessel contained all 113 
three histological layers such as the endothelium, the media and the adventitia. In  
  
Fig. 1  Laser-assisted sequential two color cell printing in 2D. a The two cell suspensions (6·107 
cells/ml in DMEM, supplemented with 1% (w/v) alginate were then printed according to a pattern 
of concentric circles). b Green Calcein stained cells within the region of interest as defined in 1a 
( dashed rectangle). c Red fluorescent Dil-LDL stained cells within the same region of interest. 
(Adapted from [34]) 
114 
this self-assembly approach, smooth-muscle cells and fibroblasts were cultured in 
115 
medium containing serum and ascorbic acid and produced their own extracellular 
116 
matrix 
(ECM). The smooth-muscle cell sheet was placed around a tubular mandrel 
117 
to produce 
the media of the vessel. A similar fibroblast cell sheet was wrapped 
118 
around the media to 
provide the adventitia after 8 weeks of maturation. Finally, 
119 
the tubular support was 
removed and endothelial cells were seeded in the lumen 
120 
to form the endothelium. The 
tissue engineered blood vessel has burst strength of 
121 
over 2500 mm Hg which is 
significantly higher than that of human saphenous veins 
122 
(1680 ± 307 mm Hg) [23]. 
Sheet-based tissue engineering has been used by the same 
123 
group to produce tissue 
engineered blood vessel (TEBV) suitable for autologous 
124 
small diameter arterial 
revascularization in adult patients. Fibroblasts were cultured 
125 
in conditions promoting 
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extracellular matrix (ECM) deposition to produce a cohe
126 
sive sheet that can be detached 
from the culture flask. This approach also eliminates 
127 
the use of smooth-muscle cells, 
whose early senescence is related with decreased 
128 
burst pressures in human models. The 
decellularized internal membrane (IM) and  
129 
living adventitia were assembled by wrapping fibroblast sheets around a temporary 
130 
Teflon coated stainless steel support tube. After weeks-long maturation and dehy
131 
dration 
to form an acellular substrate, the steel tube was removed and endothelial  
132 
cells were seeded in the lumen of living TEBV. The transplantation of these blood 
133 
vessels into dogs demonstrated good handling, suturability by the use of conven
134 
tional 
surgical techniques. Ultimately, this is an effective approach to produce a 
135 
completely 
biological and clinically applicable TEBV in spite of its relatively long 
136 
production time 
(≈ 28 weeks) which clearly prevents its urgent clinical use [22]. 
Okano and colleagues have engineered a long-lasting cardiac tissue based on 137 
a similar self-assembled sheet based approach. In their method, culture dishes are 138 first 
coated with a temperature-responsive polymer, poly (N-isopropylacrylamide) 139 
(PIPAAm). The surface is relatively hydrophobic at 37 °C allowing cells to attach 
140 and proliferate, while cooling below 32 °C (typically 20 °C for 30 min) makes the 141 
surface hydrophilic and causes the cells to detach without the use of enzyme di142 gestion 
reagent. When grafted PIPAAm layer thickness is between 15 and 20 nm, 143 temperature-
dependent cell adhesion and detachment can be observed. Once the 144 cells spread and 
confluent on the surface, they can be spontaneously detached as a 145 contiguous cell sheet 
by reducing the temperature. This process does not disrupt the 146 cell-cell junctions because 
no enzymes like trypsin are required. Additionally, basal 147 surface extracellular matrix 
(ECM) proteins such as fibronectin are preserved after 148 detachment which enables easy 
attachment of cell sheets to host tissues and even 149 wound sites with minimal cell loss. In 
order to obtain tissue constructs with char150 acteristic physiological cellular functions in 
vitro, heterotypic cell-cell interactions 151 are inevitable. As shown in Fig. 2, it is possible to 
modify the above-mentioned 152 technique in order to develop patterned cell sheets using two 
or more kinds of cell 153 source. Domains on petri dishes were grafted by using area-selective 
electron beam 154 polymerization of PIPAAm. After cells were cultured on the patterned 
grafted sur155 faces at 37 °C, the temperature was decreased to 20 °C. Cells on the PIPAAm 
sur156 face are detached where other cell types were seeded subsequently by increasing the 
157 temperature to 37 °C. Therefore, two cell types can be co-cultured in desired places 158 
which improve cellular functions [18, 38, 39]. Three-dimensional myocardial tubes  
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Fig. 2  Schematic diagram of methods of cell seeding for patterned co-culture on PIPAAm-grafted 
surfaces. (Adapted from[40]) 
159 were fabricated using neonatal rat cardiomyocyte sheets cultured on temperature160 
responsive culture dishes [40, 41]. Due to the functional gap junction formation, 161 electrical 
coupling of cardiomyocyte sheets was obtained quickly and the construct 162 was implanted 
[42]. Four weeks after the implantation, the myocardial tubes were 163 integrated with the 
host tissues showing spontaneous and synchronized pulsation 164 [38, 43]. Using this 
versatile method, functional and transplantable tissue sheets are 165 produced from different 
cell types including epidermal keratinocytes [44], kidney 166 epithelial cells [45] and 
periodontal ligaments [46, 47]. 
167 Two-dimensional cell patterning or cell-sheet based approaches have been suc- 
168 cessful tissue engineering approaches. However, the engineered constructs 
fabri169 cated with these methods are limited to 2D cell patterns or simple shapes 
because 170 of the flat and uncontrolled shape of the cell sheets. In addition, many 
sheets also 171 need to be culminated in high amount of cells which requires pre-
vascularization 172 of the sheets for 3D tissue constructs. Therefore, several 
bioprinting approaches 173 have been developed for fabricating 3D tissue 
constructs with live cells. Two major 174 approaches, ink-jet based and extrusion 
based 3D bioprinting methods will be ex175 plained in details below. 
176 
177 
 178 2.2   Inkjet-Based Bioprinting 
179 
180 
In inkjet-based bioprinting, a bioink made of cells and biomaterials are printed in 
181 
the 
form of droplets through cartridges onto a substrate. There are two types of 
182 
inkjet printing 
including continuous inkjet printing (CIJ) and drop-on-demand ink
183 
jet printing (DOD). In 
CIJ mode, a jet is obtained by forcing the liquid through an 
184 
orifice under an external 
pressure and it breaks up into a stream of droplets. In DOD 
185 
mode, a pressure pulse is 
applied into the fluid which generates drops only when 
186 
needed. For ink-jet printing of 
cells, there are two most commonly used approaches: 
187 
thermal and piezo-electric inkjet 
printing. For thermal inkjet printing, small vol
188 
umes of the printing fluid are vaporized by 
a micro-heater to create the pulse that 
189 
expels droplets from the print head. In piezoelectric 
inkjet printing, a direct me
190 
chanical pulse is applied to the fluid in the nozzle by a 
piezoelectric actuator, which 
191 
causes a shock wave that forces the bioink through the 
nozzle [48]. However, there 
192 
have been only a few examples of cell deposition by 
piezoelectric ink-jet printing 
193 
due to the electrically conducting ink formulations and 
contamination concerns on 
194 
ink recycling [24]. 
195 
Inkjet-based bioprinting (Fig. 3) enables to deposit different cell types in precise 
196 
orientations relative to the print surface and to each other at micrometer resolution 
197 
by 
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controlling the ejection nozzles and timing of spray [49]. Wilson and Boland first 
198 
adapted 
the ink-jet printers for the manufacture of cell and protein arrays, which  
199 
have the advantage of being fully automated and computer controlled [50]. In their 
200 
next study, cell aggregates were printed onto thermosensitive gels layer-by-layer 
201 
in order 
to demonstrate the fusion between the closely-placed cell aggregates [51].  
202 The same group deposited CHO cells and rat embryonic motoneurons as an ‘ink’  
  
AQ1 
Fig. 3  Schematic diagram of inkjet bioprinting methods of cells with fibrin channel scaffold printed 
microvasculature. a Printed perpendicular microvasculature cultured for 14 days. b Integrity of the 
printed structure stained using Texas Red conjugated dextran molecules of 3000 MW. c Printed 
ring shaped microvasculature cultured for 21 days. d Integrity of printed structure cultured for 21 
days 
203 onto several ‘bio-papers’ made from soy agar and collagen gel. They demonstrated  
204 also that the mammalian cells can be effectively delivered by a modified thermal  
205 inkjet printer onto biological substrates and that they retain their ability to function  
206 
[52]. Cui and Boland used also thermal inkjet printing to produce cell containing  
207 fibrin channels by printing human microvascular endothelial cells onto thin layers  
208 of fibrinogen as shown in Fig. 3. During the incubation period, the cells proliferated  
209 and formed branched tubular structures mimicking simple vasculature [53]. 
210 
Inkjet bioprinting has been progressed to fabricate 3D biological structures by  
211 the use of readily crosslinked hydrogels such as alginate. In published studies, cells  
212 have been mixed with alginate solutions and crosslinked with calcium chloride to  
213 create cell encapsulating hydrogels having defined 3D structures [54–56]. In a more  
214 recent study, alginate has been used as a constituent of bioink and it was mixed with  
215 
NIH 3T3 mouse fibroblasts cell suspension in order to fabricate zigzag cellular  
216 tubes with an 
overhang structure 
using a platform-
assisted 3D inkjet 
bioprinting  
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217 system [57]. 
218 
Although inkjet bioprinting has been one of the most commonly used method  
219 in printing living cells and biomaterials, cell aggregation, sedimentation and cell- 
220 damage because of the high shear stresses are common drawbacks of this method.  
221 
Cell aggregation and sedimentation may be prevented by frequent stirring of the  
222 cell mixture, which can result in reduced cell viability if the cells are sensitive to the  
223 shear forces [58]. Another problem limiting the inkjet bioprinting is the clogging  
224 of the nozzle orifice. Low viscosity surfactants can be added to the ink which can  
225 cause additional challenges such as cell damage [59]. 
226 
Recently, two research groups successfully address the sedimentation and cell  
227 aggregation problem during the inkjet bioprinting. Chahal and coworkers used a  
228 surfactant (Ficoll PM400) create neutrally buoyant MCF-7 breast cancer cell sus- 
229 pensions, which were ejected using a piezoelectric drop-on-demand inkjet printing  
230 
system. They demonstrated that Ficoll PM400 did not have adverse effects on cell  
231 viability. Moreover, neutrally buoyant suspension greatly increased the reproduc232 ibility 
of consistent cell counts, and eliminated nozzle clogging. [60]. 
233 Ferris et al. used two different commercially available drop-on-demand printing 234 
systems in order to reproducibly print several different cell types over long printing  
235 periods. The bio-ink based on a novel microgel suspension in a surfactant-contain236 ing 
tissue culture medium can prevent the settling and aggregation of cells, while 237 meeting the 
stringent fluid property requirements needed for many-nozzle commer238 cial inkjet print 
heads. They could print two cells types simultaneously from two 239 different inkjet print 
heads, which is a innovative way to biofabricate more complex 240 multi-cellular structures 
[61]. 
241 
242 
 243 2.3  Self-Assembly Based Bioprinting  
244 
245 
The autonomous organization of components from an initial state into a final pattern 
246 
or structure without external intervention is called self-assembly. The aim of the  
247 
self-assembly-based bioprinting is the use of the inherent organizational capacity of 
248 
cells into tissues and eventually organs by mimicking natural morphogenesis. The  
249 best examples of tissue self-organization and self-assembly are in the field of devel- 
250 opmental biology and scaffold-free biomimetic approach has deep roots in 
develop
251 
mental biology [20]. Malcolm Steinberg published papers, in which he 
formulated 
252 
fundamental thermodynamic rules determining tissue self-assembly 
and developed  
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253 
differential adhesion hypothesis (DAH) explaining the fluidic nature of cell sorting 
254 
and tissue self-assembly [62–64]. Therefore, the novel scaffold-free biomimetic tis255 sue 
engineering paradigm relies on the principle that in vitro tissue assembly from 
256 
single cells 
or tissue aggregates is feasible. 
257 
Based on the self-assembly principle, it is possible to fabricate reliable and re
258 
producible 3D tissue constructs having defined topology and functionality in vitro 
259 
when 
combined with bioprinting techniques. The disadvantage of this method is  
260 
that the development of the natural ECM is time consuming and in vitro self-as
261 
sembly 
may vary with fully physiological conditions. The bioprinting of 3D tissue  
262 
constructs is achieved via a three-phase process: (1) preprocessing or bio-ink prepa
263 
ration; (2) processing, i.e. the actual automated deliver/printing of the bio-ink parti
264 
cles 
into the bio-paper by the bioprinter; and (3) postprocessing, i.e. the maturation/ 
265 
incubation of the printed construct in the bioreactor [19]. Self-assembly occurs in an 
266 
in vivo like, fully controllable cell environment (bioreactor) by the differentiation of 
267 
cells 
at the right time, in the right place and into the right phenotype and eventually 
268 
the 
assembly of them to form functional tissues. Based on this approach, a perfusion 
269 
reactor 
is used for the maturation of a bioprinted macrovascular network in order  
270 
to obtain the required mechanical properties. Microvascular units consisting of cy
271 
lindrical or spherical multicellular aggregates were fabricated by the parenchymal 
272 
and 
endothelial cells. Afterwards, microvascular units were located in the macro
273 
vascular 
network for the perfusion supporting self-assembly and the connection to  
 274 the existing network. Multicellular spherical and cylindrical aggregates have been  
275 
276 
277 
278 
279 
280 
281 
282 
283 
284 
285 
286 
287 
288 
289 
290 
291 
292 
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Fig. 4  a Organovo bioprinter with cell and hydrogel printing heads and schematics to print tubular 
structures with cellular spheroids: layer-by-layer deposition of spheroids into the hydrogel. b 
Cross-section of a vascular graft printed with four central rods 12 h post-printing. All cellular 
cylinders have fused to form a continuous conduit. c A vascular construct (ID =600 μm) at 14 days 
post-perfusion. (Adapted from [25]) 
  
constructed by using 3D printing methods, which enable to achieve flexibility in  
tube diameter and wall thickness and to form branched tubular structures. However,  
the printed cell aggregates should be perfectly supported by hydrogels for 3D print- 
ing [ 21 ] . Forgacs and his group employed this novel technology to print cellular  
topologically defined structures of various shapes. Cardiac constructs were built  
using embryonic cardiac and endothelial cells and their postprinting self-assembly  
resulted in synchronously beating solid tissue blocks, where the endothelial cells  
were organized into vessel-like conduits [ 65 ] . In their more recent study, the same  
group utilized the self-assembly approach in order to bioprint small-diameter, multi- 
layered, tubular vascular and nerve grafts using bio-ink composed of aortic smooth  
muscle cells (HASMC), human aortic endothelial cells (HAEC), human dermal  
fibroblasts (HDFb) and bone marrow stem cells (BMSC), respectively as shown  
in Fig.   4 [ 25 ] . Similarly, in another study, self-assembled cell-based microtissue  
blocks were used to generate small diameter tissue-engineered living blood vessels  
( TEBV). Microtissues composed of human-artery-derived fibroblasts (HAFs) and  
endothelial celss (HUVECs) were cultured for 7 and 14   day under pulsatile flow/ 
mechanical stimulation in a designed bioreactor or static culture conditions with  
a diameter of 3   mm and a wall thickness of 1   mm. Self-assembled microtissues  
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Fig. 5  Bioprinting of aortic valve conduit. a Aortic valve model reconstructed from micro-CT 
images. The root and leaflet regions were identified with intensity thresholds and rendered 
separately into 3D geometries into STL format ( green color indicates valve root and red color 
indicates valve leaflets); b, c schematic illustration of the bioprinting process with dual cell types 
and dual syringes; b root region of first layer generated by hydrogel with SMC; c leaflet region of 
first layer generated by hydrogel with VIC; d fluorescent image of first printed two layers of aortic 
valve conduit; SMC for valve root were labeled by cell tracker green and VIC for valve leaflet 
were labeled by cell tracker red. e as-printed aortic valve conduit. (Reproduced with permission 
[75]). 
293 composed of fibroblasts showed accelerated ECM formation and a layered tissue AQ2 
formation was obtained only in flow/mechanical stimulation conditions [66] Fig. 5. 294 
295 An alternative approach for multicellular spheroid assembly technique for bio296 
fabrication was developed by Nakayama and his group. In their technique, they 297 used a so 
called needle-array system instead of using a bioprinter. A robotic system 298 was developed 
in order to skewer the multicellular spheroids into medical-grade  
299 stainless needles, which served as temporal fixators until multicellular spheroids 300 fused 
each other. They could fabricate complex 3D scaffold-free cell constructs 301 with different 
types of cells including chondrocyte, hepatocyte, cardiomyocyte and 302 vascular smooth 
muscle cell. One of the advantages of this technique is the easy 303 removal of the temporary 
supports without contamination with exogenous materi- 
304 als [3]. 
305 Apart from the above mentioned applications, a new method is presented to rap306 
idly self-assemble cells into 3D tissue rings without the use of additional equip307 
ment. This method enables fabrication of engineered tissue constructs entirely from 
308 cells by seeding cells into custom made annular agarose wells with 2, 4 or 6 mm 
309 inside diameters. Different cell types including rat aortic smooth muscle cells 
and  
310 human smooth muscle cells are used with varying seeding conditions and culture 
length to form tissue rings. The strength and modulus of tissue rings increased with  
311 ring size and decreased with culture duration. Rat smooth muscle cell rings with 
an 312 inner diameter of 2 mm are cohesive enough for handling after 8 days 
incubation 313 and they yield at 169 kPa ultimate tensile strength. Furthermore, it 
is also pos314 sible to fabricate tissue tubes by transferring the rings onto silicone 
tubes, sliding 315 them into contact with one another and incubating them for an 
additional 7 days. 316 Although these rings are not as strong as ring segments of 
native blood vessels or 317 TEBV fabricated from cell sheets for 2–3 months, the 
presented method allows de318 veloping 3D tissue constructs from aggregated cells 
within an experimentally useful 
319 
time frame (1–2 weeks) [67]. Likewise created 
smooth muscle cell tissue rings and 320 rings fabricated from cells seeded in fibrin 
or collagen gels are compared based on 321 their relative strength and utility for 
tissue engineering. All tissue rings were cul322 tured for 7 days in supplemented 
growth medium which includes ε-amino caproic  
323 acid, ascorbic acid, and insulin-transferrin-selenium. Ultimate tensile strength and 324 
stiffness values of tissue rings were two-fold higher than fibrin gel and collagen gel 325 
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rings. Tissue rings cultured in supplemented growth medium exhibit a three-fold 326 
increase in tensile strength and stiffness in comparison to the tissue rings cultured 327 in 
standard growth medium [68]. 
328 The approach of using microtissues as building blocks to form larger structures 329 is 
further used by other research groups in order to investigate the reassemble ca330 pacity of 
cell aggregates. After a preculture period for 7 days of HUVEC spheroids, 331 they were 
mixed with NHF cells and were able to reassemble and form microtissues  
332 
with the NHF cells on the inside and coated with HUVEC on the outside [69]. Ad333 
ditionally, the kinetics of the cellular self-assembly also differs from one cell type to 334 the 
other. While H35 cells formed relatively stable rod structures inside the recesses 335 of 
micromolded agarose gels, NHF cells reassembled quickly the initial rod struc336 tures to a 
final spheroid structure [70]. 
337 
338 
 339 2.4  Extrusion-Based Bioprinting  
340 
341 
Bioprinting methods based on extrusion of cell or cell-laden biomaterials use 342 
self-assembly cells to construct 3D biological constructs. The main principle of 343 
extrusion-based bioprinting techniques is to force continuous filaments of materials 344 
including hydrogels, biocompatible copolymers and living cells through a nozzle 345 with a 
help of a computer to construct a 3D structure [27]. Extrusion-based print346 ers usually 
have a temperature-controlled material handling and dispensing system 347 and stage with 
the movement capability along the x, y and z axes. The printers are 348 directed by the CAD-
CAM software and continuous filaments are deposited in two 349 dimensions layer-by-layer 
to from 3D tissue constructs. The stage or the extrusion 350 head is moved along the z axis, 
and the printed layers serve as a base and support 351 for the next layer. Pneumatic or 
mechanical (piston or screw) are the most common 352 techniques to print biological 
materials for 3D bioprinting applications [33]. Ad353 ditionally, novel multi-nozzle 
biopolymer deposition systems were developed for 354 freeform fabrication of biopolymer-
based tissue scaffolds and cell-embedded tissue  
355 constructs [71, 72]. 356 
357 An extrusion-based printer was used to deposit living cells by Williams and 358 co-workers. 
Instead of using a thermally crosslinked biomaterial, which can flow  
359 at room temperature, but crosslink into a stable material at body temperature, 360 they used 
Pluronic F-127 and type I collagen to encapsulate human fibroblasts 361 and bovine aortic 
endothelial cells (BAECs) separately. These materials flow at 362 physiologically suitable 
temperatures (35–40°), but crosslink at room tempera363 ture. They demonstrated the 
availability of CAD/CAM technology to fabricate 364 anatomically correct shaped constructs 
and also examined several environmental 365 factors with respect to the viability of the 
extruded cells [73, 74]. Recently, dif366 ferent research groups used the similar extrusion 
systems in order to fabricate 367 anatomically accurate and mechanically heterogeneous aortic 
valves as shown in 368 Fig. 1 [75, 76]. 
369 Several groups used high resolution extrusion systems to print different type of 370 cells 
encapsulated in various hydrogels. For instance, Chang et al. printed HepG2  
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371 cell encapsulated sodium alginate through a pneumatically powered nozzle and ex372 
amined the process parameters, the dispensing pressure and the nozzle diameter, 373 regarding 
to the cell viability and recovery [77]. In another study, alginate hydrogel 374 was used with 
calcium sulfate as a crosslinking agent to fabricate pre-seeded im375 plants of arbitrary 
geometries and the printed constructs showed high viabilities 376 [78]. Although the cell 
viability after printing is important, it is also important that 377 the cells perform their essential 
functions in the tissue constructs. 
378 Extrusion-based printing allows the construction of organized structures within 379 a 
realistic time frame, and hence it is the most promising bioprinting technology.  
380 The main advantage of extrusion-based bioprinting is the ability to print very high 381 cell 
densities. Some groups developed 3D bioprinters in order to use multicellular 382 spheroids or 
cylinders as bioink to create 3D tissue constructs [19, 21, 25, 79–81]. 383 However, preparing 
bioink requires time-consuming manual operation and makes 384 totally automated and 
computer-controlled 3D bioprinting impossible in earlier  
385 studies. Therefore, our group focused on the development of a continuous bioprint386 ing 
approach in order to extrude cylindrical multicellular aggregates using an ex387 trusion-based 
bioprinter, which is an automated, flexible platform designed to fab388 ricate 3D tissue 
engineered cell constructs. In order to bioprint anatomically correct 389 tissue constructs 
directly from medical images, the targeted tissue or organ must be 390 biomodeled. In the 
following section, the details of modeling and developing path 391 planning for automated 
direct cell bioprinting will be explained. 
392 
393 
394 2.4.1   Biomodeling 
395 
396 In order to obtain an anatomically accurate tissue constructs, several imaging meth397 ods 
for data acquisition of tissue organ such computed tomography (CT) and mag398 netic 
resonance imaging (MRI) could be used. The obtained medical images are  
399 then transferred to a special segmentation software, where the images are represented with 
stack of numerous planar scan captures (Fig. 6a). The segmented 3D  
 14 S. B. Ozler et al. 
400 
401 
402 
403 
404 
405 
406 
407 
408 
409 
410 411 
412 
413 
  
surface geometry is transformed to a CAD model which is a mesh model of the  
object (Fig.  6 b ) . In order to generate bioprinting path planning as well as the topol - 
ogy optimization for bioprinting processes, the resultant mesh models need to be  
represented by smooth parametric surfaces. The mesh model is then sliced with  
consecutive planar cross-sections, resulting in closed contour curves for each thin  
layer slice [ 28  (Fig. ]  c 6 . Those contour curves are basically the surface boundaries  ) 
of tissue constructs. Obtained contour curves need to smoothed by B-spline curve  
fitting from their control points, in order to generate smooth parametric surfaces  
and finer surface geometry (Fig.   6 d . The resultant CAD model is then ready to  ) 
be used for path planning and topology optimization purposes for biomimetic 3D  
bioprinting. 
Recently, novel computer-aided algorithms and strategies are developed to model  
and 3D bioprint a scaffold-free human aortic tissue construct biomimetically by our  
group. Medical images obtained from magnetic resonance imaging (MRI) are used  
Fig. 6    Biomodeling of the bioprinted tissue/organ  a segmentation of the targeted tissue/organ  b   
mesh model of segmented model  c slicing of CAD model 
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Fig. 7  Biomimetic modeling of aorta directly from medical images a segmentation from medical 
images b Conversion to a CAD model 
414 
to obtain the geometric and topological information of the targeted aorta. In order to 
415 
obtain 3D computer models of the aortic tissue, MRI images are segmented using a 
416 
segmentation software and converted into CAD model (Fig. 7). For tool path plan
417 
ning as 
well as for optimization of 3D bioprinting, the resultant mesh model of aorta 
418 
converted 
to a CAD model with smooth parametric surfaces. Three-dimensional 
419 
bioprinting path 
planning and parameter optimization are then developed. The de
420 
veloped self-supporting 
methodology is used to calculate corresponding tool paths 
421 
for both cell aggregates and 
the support structures, which control the bioprinter for 
422 
3D printing of a biomimetic aortic 
construct [74]. 
423 
424 
425 
2.4.2   Path Planning and Optimization for Bioprinting 426 
427 
In order to bioprint an anatomically correct tissue constructs with live cells layer-by
428 
layer, the generated computer model of this construct needs to be sliced by planar  
429 
cross-sections, resulting in closed contour curves for each layer. Then those layers 
430 
need to be filled by appropriate types of cellular aggregates with supportive hydro
431 
gel 
walls surrounding them for keeping the biomimetic form. In our recent work, 
432 
multicellular cell aggregates are 3D bioprinted based on computer-aided continuous 
433 
and, 
interconnected tool-path planning methodologies. Continuous bioprinting en
434 
ables to 
design and 3D bioprint extruded multicellular aggregates according to the  
435 
computer model of the targeted tissue. The Zig-zag and Contour Offsetting pattern 
436 
tool-path methodologies are developed to 3D bioprint different shaped structures 
437 
with 
multiple layers. A CAD software package was used for developing algorithms 
438 
for 
continuous and connected bioprinting path plans. In order to keep the 3D forms 
439 
of printed 
structures during the maturation period, a biocompatible and bio-inert  
440 
agarose-based hydrogel was used as a support material [75]. The developed bio
441 
printing process starts from the bottom layer and follows the generated path plan for 
442 
each 
particular layer consecutively through the top layer. At a layer, support mate
443 
rial enclosing 
the cellular aggregates are printed first, and then cellular aggregates 
444 
are deposited to fill 
the respective contour areas. 
445 In Fig. 8, schematic view of pat planning strategies are showed for a layer. Figure 
8a-b shows Zig-zag whereas Fig. 8c-d shows Contour Offsetting path planning.  
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446 In both Zig-zag and Contour Offsetting patterns, outer supportive hydrogel walls’ 
447 tool path are generated with offsetting the contour curve with a deposited cellular 
448 or hydrogel extrusion diameter. Placement of support structures before the 
cellular 449 aggregates provides necessary conditions for cell fusion and structure 
conservation. 450 In Zig-zag pattern path planning strategy, contour curves are 
Fig. 8    Path planning for bioprinting  a – b Zig-zag pattern  c – d Contour offsetting path planning 
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crossed with par451 allel consecutive lines, each separated by extrusion diameter, 
and an intersection 452 point is generated for each cross as shown in Fig. 8a. Zig-
zag pattern path planning 453 strategy aims to fill the contour area by following 
a zig-zag patterned path way be454 tween the generated intersection points 
as uninterrupted as possible. 
455 In Contour Offsetting path plan strategy, cellular aggregates’ path plan is formed 456 by 
offsetting the contour curve to fill the entire area. After the necessary amount 457 of offset 
curves is generated, they are joined by small line segments to enable con458 tinuous 
bioprinting. That strategy also aims to fill the contour area with minimum 459 number of 
cellular aggregate as shown in Fig. 8c). 
460 After the path plan is calculated, the coordinates of these movements are trans461 ferred 
to bioprinter to guide the deposition path plan in order to obtain anatomically  
462 correct tissue constructs. In Fig. 8b and Fig. 8d, the finalized generated path plans 463 of 
cellular aggregates (red) and support structures (blue) are shown for both path 464 planning 
strategies. 
465 
466 
 467 2.4.3   Continuous Cell Printing 
468 
469 In our recent work, a novel bioprinting method is used for precise deposition of mul470 
ticellular aggregates composed of different combinations of mouse aortic smooth  
471 muscle cells (MOVAS), NIH 3T3 mouse fibroblast cells, human umbilical vein 472 
endothelial cells (HUVEC), and human dermal fibroblast (HDF) cells according 473 to 
computer-generated paths as shown in Fig. 9 [83]. The proposed methodology 474 increases 
the contact of cylindrical multicellular aggregates in adjacent bioprinted 475 layers, facilitates 
the fusion of cells and accelerates the maturation process. More 476 significantly, this 
procedure reduces the human intervention at forming of cylindri477 cal multicellular 
aggregates and therefore, increases the reproducibility. 
478 The printed 3D multicellular structures are examined for their mechanical 479 strength, 
shape deformation with time, cell viability and cell fusion. The printed 480 constructs having 
different shapes deformed during the incubation period (up to  
481 10-days) and generally a shrinking between 20 – 38 % was observed. After 4 or 7 482 days 
incubation, the support structures of well-defined and random-shaped printed 483 structures 
composed of MOVAS, HUVEC and NIH 3T3 multicellular aggregates 484 were manually 
removed and the fused cell structures could be transferred with for485 ceps into a falcon filled 
with PBS (Fig. 10a). It is remarkable that the stripe shaped 486 constructs composed of 
HUVEC/HDF cell aggregates had a small deformation per487 centage 85 % after 3-days 
incubation) and were sufficiently sturdy to be handled 488 and transferred as shown in Fig. 
10b.[83]. MOVAS/HUVEC/NIH 3T3 multicellular 489 aggregates fused within 3 days, 
which corresponds to earlier studies [25, 81]. The 490 cell viability upon implementation was 
high (97 %) showing that the cellular bio491 ink preparation method is successful in 
comparison to other studies in literature. It  
492 seems that multicellular aggregates composed of human cells have better 
mechanical properties. 
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506 
3     Conclusion and Discussion on Stem Cell Printing 
Bioprinting is one of the most promising techniques in tissue engineering, where  
living cells are deposited layer-by-layer with or without biomaterials in user-de- 
fined patterns to build 3D tissue constructs. However, there are some challenges  
related with technical, material and cellular aspects. 3D bioprinting technology  
requires increased resolution, speed and compatibility with biologically relevant  
materials. Especially, the fabrication speed must be increased to create structures of  
clinically relevant sizes. Even the cells used for bioprinting applications are robust  
enough to survive the bioprinting process and withstand the physiological stresses;  
a large cell construct in an open environment may not survive a slow and there- 
fore long printing process. For bioprinting, well-characterized and reproducible  
source of cells is required and any cell type selected for printing should be able to  
be proliferated into sufficient numbers for printing. Additionally, the proliferation  
Fig. 9    Continuous bioprinting of live cells directly from computer models  a   Rectangular shaped  
b Random-shaped  c Zig-zag patterned  circular   d Spiral patterned circular printed structures [ 83 ] 
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525
 of compression on the viability and differentiation of stem cells should be con526
 sidered. Since the stem cells are more susceptible to bioprinting conditions, more 527
 gentle and short printing procedures should be developed. Although the current 3D 
rate and the differentiation with small molecules or other factors should be con- 
trollable. Furthermore, sufficient vascularization and capillaries/microvessels are  
required for long-term viability of the fabricated construct and for tissue perfusion,  
respectively. The engineered structure should have suitable mechanical properties  
for physiological pressures and for surgical connection in case of transplantation.  
Bioreactors are used to maintain tissues in vitro and to provide maturation factors  
as well as physiological stressors for assembly, differentiation and ECM production  
prior to in vivo implantation. 
Stem cells such as mesenchymal, induced pluripotent and embryonic stem cells  
could be a great source for bioprinting. Especially, printing differentiated or pro- 
genitor cells precisely and spatially could lead to multi-functional tissue constructs  
or even organs. However several challenges need to be overcome. First, bioprinting  
with stem cells requires large number of cells. Culturing this amount of stem cells  
could be really difficult. Especially, growing large number of stem cells on a feeder  
layer or special growth medium is really challenging. Even after culturing enough  
number of stem cells, bioprinting stem cells precisely and spatially accurate manner  
would require highly precise and special bioprinters. During bioprinting, the effect  
Fig. 10    Bioprinted 3D totally biological tissue constructs without any biomaterial.  a   Circular and  
square shaped bioprinted with MOVAS, HUVEC and NIH 3T3 multicellular aggregates.  b Stripe  
shaped bioprinted with HUVEC/HDF cell aggregates [ 83 ] 
  
 20 S. B. Ozler et al. 
528 bioprinting technology shows a great deal of promise to generate 3D layered con529
 structs using live mixed cell populations, there is still a long way to go to create a 530
 fully-functional organ. 
531 
532 
533 
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